Pharmacovigilance in developing countries (part I): importance and challenges.

about

Pharmacovigilance in developing countries (part I): importance and challenges.

Item

http://www.wikidata.org/entity/Q48105245

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Pharmacovigilance in developing countries (part I): importance and challenges.

@en

type

Item

label

Pharmacovigilance in developing countries (part I): importance and challenges.

@en

prefLabel

Pharmacovigilance in developing countries (part I): importance and challenges.

@en

P1476

Pharmacovigilance in developing countries (part I): importance and challenges

@en

P2093

Anne Marie Roberti

http://www.w3.org/2001/XMLSchema#string

Iman Zaghloul

http://www.w3.org/2001/XMLSchema#string

P2860

Specific features of medicines safety and pharmacovigilance in Africa

Community pharmacists' knowledge and perceptions about adverse drug reactions and barriers towards their reporting in Eastern region, Alahsa, Saudi Arabia.

Self medication with antibiotics in Yogyakarta City Indonesia: a cross sectional population-based survey.

Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa.

The missing voice of patients in drug-safety reporting.

Systematic review and meta-analysis of ethnic differences in risks of adverse reactions to drugs used in cardiovascular medicine.

Assessment of global reporting of adverse drug reactions for anti-malarials, including artemisinin-based combination therapy, to the WHO Programme for International Drug Monitoring.

Under-reporting of adverse drug reactions : a systematic review.

Adverse Drug Reaction Reporting in Africa and a Comparison of Individual Case Safety Report Characteristics Between Africa and the Rest of the World: Analyses of Spontaneous Reports in VigiBase®

Pharmacovigilance: methods, recent developments and future perspectives.

P2888

s11096-017-0570-z

P304

758-763

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11096-017-0570-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Shaimaa Elshafie

P577

2018-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29248988

http://www.w3.org/2001/XMLSchema#string